Literature DB >> 28321604

Suppression of the Smurf1 Expression Inhibits Tumor Progression in Gliomas.

Hao Chang1, Jingning Zhang1, Zengli Miao1, Yasuo Ding2, Xing Xu1, Xudong Zhao1, Peng Xu3, Qing Wang1, Yuchang Lin4.   

Abstract

Glioblastoma, one of the common malignant brain tumors, results in the highly death, but its underlying molecular mechanisms remain unclear. Smurf1, a member of Nedd4 family of HECT-type ligases, has been reported to contribute to tumorigenicity through several important biological pathways. Recently, it was also found to participate in modulate cellular processes, including morphogenesis, autophagy, growth, and cell migration. In this research, we reported the clinical guiding significance of the expression of Smurf1 in human glioma tissues and cell lines. Western blotting analysis discovered that the expression of Smurf1 was increased with WHO grade. Immunohistochemistry levels discovered that high expression of Smurf1 is closely consistent with poor prognosis of glioma. In addition, suppression of Smurf1 can reduce cell invasion and increase the E-cadherin expression, which is a marker of invasion. Our study firstly demonstrated that Smurf1 may promote glioma cell invasion and suppression of the Smurf1 may provide a novel treatment strategy for glioma.

Entities:  

Keywords:  Apoptosis; Glioma; Migration; Smurf1

Mesh:

Substances:

Year:  2017        PMID: 28321604     DOI: 10.1007/s10571-017-0485-1

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  30 in total

Review 1.  Molecular targeting of glioblastoma: Drug discovery and therapies.

Authors:  Ren-Yuan Bai; Verena Staedtke; Gregory J Riggins
Journal:  Trends Mol Med       Date:  2011-03-14       Impact factor: 11.951

2.  Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.

Authors:  Zvi R Cohen; Srinivas Ramishetti; Naama Peshes-Yaloz; Meir Goldsmith; Anton Wohl; Zion Zibly; Dan Peer
Journal:  ACS Nano       Date:  2015-01-08       Impact factor: 15.881

3.  Spy1 induces de-ubiquitinating of RIP1 arrest and confers glioblastoma's resistance to tumor necrosis factor (TNF-α)-induced apoptosis through suppressing the association of CLIPR-59 and CYLD.

Authors:  Zongmei Ding; Yonghua Liu; Li Yao; Donglin Wang; Jianguo Zhang; Gang Cui; Xiaojing Yang; Xianting Huang; Fang Liu; Aiguo Shen
Journal:  Cell Cycle       Date:  2015-05-27       Impact factor: 4.534

Review 4.  A Smurf1 tale: function and regulation of an ubiquitin ligase in multiple cellular networks.

Authors:  Yu Cao; Lingqiang Zhang
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

5.  Upregulation of B23 promotes tumor cell proliferation and predicts poor prognosis in glioma.

Authors:  Jianguo Chen; Jie Sun; Liu Yang; Yaohua Yan; Wei Shi; Jinlong Shi; Qingfeng Huang; Jian Chen; Qing Lan
Journal:  Biochem Biophys Res Commun       Date:  2015-09-04       Impact factor: 3.575

Review 6.  Multimodal imaging of gliomas in the context of evolving cellular and molecular therapies.

Authors:  Olivier Keunen; Torfinn Taxt; Renate Grüner; Morten Lund-Johansen; Joerg-Christian Tonn; Tina Pavlin; Rolf Bjerkvig; Simone P Niclou; Frits Thorsen
Journal:  Adv Drug Deliv Rev       Date:  2014-07-28       Impact factor: 15.470

7.  Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.

Authors:  Simona Daniele; Barbara Costa; Elisa Zappelli; Eleonora Da Pozzo; Simona Sestito; Giulia Nesi; Pietro Campiglia; Luciana Marinelli; Ettore Novellino; Simona Rapposelli; Claudia Martini
Journal:  Sci Rep       Date:  2015-04-21       Impact factor: 4.379

Review 8.  Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods.

Authors:  Rafay Ahmed; Matthew J Oborski; Misun Hwang; Frank S Lieberman; James M Mountz
Journal:  Cancer Manag Res       Date:  2014-03-24       Impact factor: 3.989

9.  SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma.

Authors:  Ali Khammanivong; Raj Gopalakrishnan; Erin B Dickerson
Journal:  Mol Cancer       Date:  2014-12-03       Impact factor: 27.401

10.  The Effect of Chemoradiotherapy with SRC Tyrosine Kinase Inhibitor, PP2 and Temozolomide on Malignant Glioma Cells In Vitro and In Vivo.

Authors:  Keun-Yong Eom; Bong Jun Cho; Eun Jung Choi; Jin-Ho Kim; Eui Kyu Chie; Hong-Gyun Wu; Il Han Kim; Sun Ha Paek; Jae-Sung Kim; In Ah Kim
Journal:  Cancer Res Treat       Date:  2015-06-04       Impact factor: 4.679

View more
  6 in total

Review 1.  Targeting the Ubiquitin System in Glioblastoma.

Authors:  Nico Scholz; Kathreena M Kurian; Florian A Siebzehnrubl; Julien D F Licchesi
Journal:  Front Oncol       Date:  2020-11-25       Impact factor: 6.244

2.  Overexpressed Smurf1 is degraded in glioblastoma cells through autophagy in a p62-dependent manner.

Authors:  Da Han; Shengzhen Li; Qin Xia; Xinyi Meng; Lei Dong
Journal:  FEBS Open Bio       Date:  2021-11-15       Impact factor: 2.693

3.  Smurf1 silencing restores PTEN expression that ameliorates progression of human glioblastoma and sensitizes tumor cells to mTORC1/C2 inhibitor Torin1.

Authors:  Qin Xia; Wenxuan Li; Sakhawat Ali; Mengchuan Xu; Yang Li; Shengzhen Li; Xinyi Meng; Liqun Liu; Lei Dong
Journal:  iScience       Date:  2021-11-27

4.  A Radiosensitivity Prediction Model Developed Based on Weighted Correlation Network Analysis of Hypoxia Genes for Lower-Grade Glioma.

Authors:  Zixuan Du; Hanshan Liu; Lu Bai; Derui Yan; Huijun Li; Sun Peng; JianPing Cao; Song-Bai Liu; Zaixiang Tang
Journal:  Front Oncol       Date:  2022-02-25       Impact factor: 6.244

Review 5.  SMURF1, a promoter of tumor cell progression?

Authors:  Qin Xia; Yang Li; Da Han; Lei Dong
Journal:  Cancer Gene Ther       Date:  2020-11-17       Impact factor: 5.987

6.  Oncogenic Smurf1 promotes PTEN wild-type glioblastoma growth by mediating PTEN ubiquitylation.

Authors:  Qin Xia; Hanwen Zhang; Pei Zhang; Yang Li; Mengchuan Xu; Xiaobo Li; Xuejun Li; Lei Dong
Journal:  Oncogene       Date:  2020-07-31       Impact factor: 9.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.